Potentum Partners

Potentum Partners is a private equity firm founded in 2019, with offices in Melbourne, Australia, and the United States. The firm specializes in providing institutional investors and high-net-worth family offices with access to private equity markets, emphasizing majority stake buyouts and minority co-investments through growth equity. Their investment approach is designed to support companies with significant scaling potential and value creation opportunities.

The firm's investment strategies include the Global Leaders Program, offering a fund of funds solution that democratizes access to exceptional, institutional-grade global private equity managers at a low cost. Additionally, Potentum Partners provides the Global Leaders Co-Investment Strategy, an annual vehicle that allows investors to participate in every co-investment transaction undertaken by the firm in the forthcoming year. They also offer Single Opportunity Investment Vehicles, providing opportunities to invest in specific funds or direct opportunities, and the Emerging Leaders Fund, which focuses on emerging managers globally, particularly in India and Southeast Asia.

Potentum Partners has established deep relationships with top-tier private equity managers over a decade, resulting in a robust pipeline of co-investment opportunities. Their portfolio includes investments in companies such as Strand Therapeutics, a biotechnology firm specializing in genetically programming mRNA to develop innovative therapies aimed at enhancing patient outcomes. This diverse portfolio reflects Potentum Partners' commitment to supporting innovative companies across various sectors and stages of development.